Nooglutyl
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
N-[(5-Hydroxy-3-pyridinyl)carbonyl]-L-glutamic acid
|
|
Other names
Nooglutil
|
|
Identifiers | |
112193-35-8 | |
3D model (Jmol) | Interactive image |
ChemSpider | 130090 |
PubChem | 147523 |
|
|
|
|
Properties | |
C11H12N2O6 | |
Molar mass | 268.23 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Nooglutyl is a nootropic agent being studied at the Research Institute of Pharmacology, Russian Academy of Medical Sciences as a potential treatment for amnesia.[1]
In animal models, it has a variety of central nervous system effects.[2][3][4][5]
References[edit]
- ^ Flekhter, Oxana B. (2000). "Nooglutil, Russian Academy of Medical Science". Current Opinion in Central & Peripheral Nervous System Investigational Drugs. 2 (4): 491–497.
- ^ V. V. Yasnetsov; V. A. Pravdivtsev; V. M. Popov; T. A. Voronina; N. M. Kiseleva; S. B. Kozlov (May 1995). "Antimotion Effect of Nooglutyl and Its Neuronal Mechanism". Bulletin of Experimental Biology and Medicine. 119 (5): 515–516. doi:10.1007/BF02543440. PMID 7579248. Retrieved 2011-02-08.
- ^ Voronina, TA; Borlikova, GG; Garibova, TL; Proskuryakova, TV; Petrichenko, OB; Burd, SG; Avakyan, GN (2002). "Effect of nooglutil on benzodiazepine withdrawal syndrome and binding of 3H-spiperone with D2 receptors in rat striatum". Bulletin of experimental biology and medicine. 134 (5): 448–50. PMID 12802448.
- ^ Garibova, TL; Galaeva, IP; Voronina, TA; Kraĭneva, VA; Kapitsa, IG; Kirichenko, SV; Makarenko, AN; Mirzoian, GR; Kuznetsova, EA (2003). "Effect of nooglutil on rats with intracerebral posttraumatic hematoma (hemorrhagic stroke)". Eksperimental'naia i klinicheskaia farmakologiia. 66 (3): 13–6. PMID 12924225.
- ^ Povarova, OV; Garibova, TL; Kalenikova, EI; Galaeva, IP; Kraĭneva, VA; Medvedev, OS; Voronina, TA (2004). "Effect of phenyl-tert-butylnitrone, mexidol and nooglutil on the ischemic lesion zone and memory in rats following middle cerebral artery occlusion". Eksperimental'naia i klinicheskaia farmakologiia. 67 (1): 3–6. PMID 15079898.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |